The ARMA procedure for GERD treatment is an endoscopic technique that uses controlled thermal ablation around part of the gastroesophageal junction. Healing and scar contraction may narrow the opening and improve the antireflux barrier. It is performed through the mouth without abdominal incisions, but it remains an interventional procedure that requires confirmed reflux, careful patient selection and specialist follow-up.
ARMA stands for anti-reflux mucosal ablation. A therapeutic endoscope is passed to the junction between the oesophagus and stomach. A planned area of mucosa is ablated while part of the circumference is left untreated. As the treated area heals, tissue contraction may reinforce the valve. ARMA does not remove part of the stomach and leaves no permanent implant.
The lower oesophageal sphincter, diaphragm and flap valve normally work together to stop stomach contents moving upwards. If this barrier is weak, acid and food can reflux. ARMA aims to reduce the width of the junction through controlled healing. Results differ according to hiatal hernia size, valve anatomy, oesophageal movement and the pattern of reflux.
Symptoms alone are insufficient. A possible candidate generally has objective evidence of GERD and understands that improvement is not guaranteed.
ARMA may be inappropriate when reflux has not been proven, when symptoms arise from functional heartburn or hypersensitivity, or when there is a large hiatal hernia, severe motility disorder, unexplained dysphagia, oesophageal narrowing, varices, suspected cancer, uncontrolled bleeding risk, pregnancy or an unstable medical condition. A large anatomical defect may require surgical repair.
Gastroscopy checks for inflammation, narrowing, Barrett's changes, ulcers and the size of a hiatal hernia. The specialist may take biopsies when indicated.
Ambulatory pH or impedance monitoring measures acid and non-acid reflux and matches episodes with symptoms. It is particularly useful when endoscopy appears normal.
Manometry evaluates contractions and sphincter function. It can identify disorders that change the treatment choice or increase the chance of swallowing difficulty.
ARMA is still an evolving technique. Early studies have reported encouraging outcomes, but study sizes, definitions of success and follow-up periods vary. A recent sham-controlled trial did not show a clearly significant difference in clinical success at 12 months, so the procedure should never be presented as a guaranteed cure.
Temporary sore throat, chest discomfort, nausea and swallowing difficulty can occur. More significant risks include bleeding, ulceration, infection, excessive scarring and narrowing, dysphagia requiring endoscopic dilation, anaesthetic complications, persistent symptoms and recurrent reflux. Severe chest or abdominal pain, inability to drink, repeated vomiting, blood in vomit, black stool, fever, breathing difficulty, fainting or dehydration needs urgent medical assessment.
The treating team may recommend clear liquids followed by full liquids and soft food while the ablated area heals. Patients should eat slowly, avoid strenuous exercise temporarily and take prescribed acid suppression or protective medicine. Medication should not be stopped without the doctor's instructions. Final benefit is assessed over weeks or months because the effect depends on healing.
Both techniques use healing and contraction to improve the junction. ARMA applies controlled ablation to the mucosal surface, while ARMS removes a selected mucosal area. Both may cause narrowing or dysphagia. The choice depends on anatomy, evidence, available expertise and the patient's risk profile.
Lifestyle measures and proton pump inhibitors remain the starting point for many patients. ARMA may be discussed for selected patients with proven reflux and limited anatomical disruption. Surgery can repair a large hiatal hernia and has more established long-term evidence, but it is more invasive. The decision should integrate endoscopy, pH testing, manometry, weight, medication response and individual priorities.
Dr Ahmed Gamal reviews the diagnosis, medicine timing and results of endoscopy, reflux monitoring and manometry before recommending treatment. This helps distinguish true reflux from other causes of burning, chest discomfort, cough or throat symptoms. See the clinic's digestive and endoscopy services and its dedicated ARMA service.
No. Symptoms and medicine use may improve, but some patients do not respond or later experience recurrent reflux.
It is performed under anaesthesia. Chest discomfort or temporary swallowing difficulty may occur during healing.
It may be considered with a small hernia in selected cases, but it does not repair a large hernia.
Only after review. Medicine is often continued during healing and may still be needed long term.
Medical notice: This information is educational and does not replace an examination. Do not stop or change reflux medication without medical advice.